T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Stella F, Fraietta JA, Schuster SJ, Ruella M

Open source

DOI
10.3324/haematol.2026.301592
Published
2026 Sep 17
Container
Haematologica
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.301592,
  title = {T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?},
  author = {Stella F and Fraietta JA and Schuster SJ and Ruella M},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.301592},
  url = {https://doi.org/10.3324/haematol.2026.301592}
}

RIS

TY  - JOUR
TI  - T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?
AU  - Stella F
AU  - Fraietta JA
AU  - Schuster SJ
AU  - Ruella M
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.301592
UR  - https://doi.org/10.3324/haematol.2026.301592
ER  - 

APA

F, S., JA, F., SJ, S., & M, R. (2026). T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?. Haematologica. https://doi.org/10.3324/haematol.2026.301592

Source records